Loading provider…
Loading provider…
Hematology & Oncology Physician in Goodyear, AZ
NPI: 1548246655Primary Employer
City of Hope Cancer Center Phoenix
cityofhope.org
HQ Phone
Get M.D. Alan's Phone Numberphone_androidMobile
Get M.D. Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
CA State Medical License
AZ State Medical License
CA State Medical License
2009
UT State Medical License
2025 - 2028
AZ State Medical License
2011 - 2027
CO State Medical License
2025 - 2027
MN State Medical License
2004 - 2009

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Internal Medicine
2003 - 2006
Fellowship • Hematology and Medical Oncology
2006 - 2009
David Geffen School of Medicine at UCLA
medschool.ucla.edu
BS • Biochemistry
1994 - 1998
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 110 | 131 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 59 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 41 | 43 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 12 | 12 |
DNA Repair and Prostate Cancer: A Field Ripe for Harvest.
Authors: Bryce, Alan H, Sartor, Oliver, de Bono, Johann
Journal: Eur Urol
Publication Date: 2020-07-05
Lead Sponsor: Masonic Cancer Center, University of Minnesota
Intervention / Treatment: DRUG: Carboplatin, DRUG: Prednisone, DRUG: Cabazitaxel, DRUG: Abiraterone
Lead Sponsor: GRAIL, Inc.
Lead Sponsor: Clarity Pharmaceuticals Ltd
Intervention / Treatment: DRUG: 64Cu-SAR-bisPSMA, DRUG: 67Cu-SAR-bisPSMA